Fas antigen expression and its relationship with apoptosis in transplanted kidney

Pathology International

Volumn 47, Issue 4, 1997, Pages 230-237

  Kato, Shigeo ^a   Akasaka, Yoshikiyo ^a   Kawamura, Sadao ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

apoptosis; Fas antigen; transplanted kidney

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; GAMMA INTERFERON; PROTEIN BCL 2;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; DIAGNOSIS; ETIOLOGY; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030893363     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04485.x     Document Type: Article

References (29)

1. Majno G, Joris I. Apoptosis, oncosis and necrosis: An overview of cell death. Am. J. Pathol. 1995; 146: 3-15.
2. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239-257.
3. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int. Rev. Cytol. 1980; 68: 251-306.
4. Umansky SR. The genetic program of cell death: Hypothesis and some applications: Transformation, carcinogenesis, aging. J. Theor. Biol. 1982; 97: 591-602.
5. Brusch W, Kleine L, Tenniswood M. The biochemistry of cell death by apoptosis. Biochem. Cell Biol. 1990; 68: 1071-1074.
6. Arends MJ, Willie AH. Apoptosis: Mechanism and roles in Pathology. Int. Rev. Exp. Pathol. 1991; 32: 223-254.
7. Koseki C, Herzlinger D, Al-Awqat Q. Apoptosis in metanephric development. J. Cell Biol. 1992; 119: 1327-1333.
8. Ledda-Columbano GM, Columbano A, Faa G, Pani P. Cell deletion by apoptosis during regression of renal hyperplasia. Am. J. Pathol. 1989; 135: 657-662.
9. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989; 169: 1747-1756.
10. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
11. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild type p53 in a human colon tumor-derived cell line. Proc. Natl Acad. Sci. USA 1992; 89: 4495-4499.
12. Evan GI, Wyllie AH, Gilbert CS et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.
13. Vanx DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 33: 440-442.
14. Takahashi T, Tanaka M, Brannan CI et al. Generalized lympho-proliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969-976.
15. Kondo E, Yoshino T, Yamadori I et al. Expression of bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am. J. Pathol. 1994; 145: 330-337.
16. Wijsman JH, Jonker RR, Keijzer R, Van de Valde CJ, Cornelisse CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 1994; 41: 7-12.
17. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992; 119: 493-501.
18. Ehlers S, Smith KA. Differentation of T cell lymphokine gene expression: The in vitro acquisition of T cell memory. J. Exp. Med. 1991; 17: 25-36.
19. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int. 1993; 44: 411-422.
20. Tanaka M, Ito H, Adachi S et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ. Res. 1994; 75: 426-433.
21. Suzuki A, Enari M, Eguchi Y et al. Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle. EMBO J. 1996; 15: 211-215.
22. Harrison DJ. Cell death in the diseased glomerulus. Histopathology 1988; 12: 679-683.
23. Schumer M, Colombel MC, Sawczuk S et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am. J. Pathol. 1992; 140: 831-838.
24. Savill J. Apoptosis and the kidney. J. Am. Soc. Nephrol. 1994; 5: 12-21.
25. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S. Constitutive and induced expression of Apo-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 1993; 69: 415-429.
26. Nogae S, Saito T. Apoptosis in ischemia-reperfusion kidney injury. J. Clin. Exp. Med. (Igaku No Ayumi) 1996; 178: 742-746.
27. Suda T, Okazaki T, Naito Y et al. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 1995; 154: 3806-3813.
28. Takemura T, Murakami K, Miyazato H et al. Expression of Fas antigen and bcl-2 in human glomerulonephritis. Kidney Int. 1995; 48: 1886-1892.
29. Ohmori J. A study of mast cells in autoimmune mice: The proliferative response of autoimmune mast cells to cytokines. Autoimmunity 1994; 17: 279-285.